Inventor · disambiguated record
Zhe Wang
Also filed as: WANG ZHE · WANG ZHE OING
69 granted patents·24 pending applications·799 citations·filing 1989–2016
99Inventor score
Top patents by PatentIndex Score
93 records- 0198US7635683B2Quinoxalinyl tripeptide hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2006·Granted Dec 22, 2009·75 cites·5 claims
- 0297US7605126B2Acylaminoheteroaryl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Oct 20, 2009·38 cites·15 claims
- 0397US7582605B2Phosphorus-containing hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted Sep 1, 2009·59 cites·9 claims
- 0497US7176208B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Feb 13, 2007·111 cites·10 claims
- 0596US7687459B2Arylalkoxyl hepatitis C virus protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Mar 30, 2010·26 cites·18 claims
- 0696US7601709B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Oct 13, 2009·60 cites·75 claims
- 0796US7368452B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted May 6, 2008·35 cites·12 claims
- 0896US7273851B2Tri-peptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2004·Granted Sep 25, 2007·65 cites·18 claims
- 0994US7662779B2Triazolyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Feb 16, 2010·14 cites·16 claims
- 1093US7566719B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2008·Granted Jul 28, 2009·20 cites·8 claims
- 1193US7125845B2Aza-peptide macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2003·Granted Oct 24, 2006·57 cites·17 claims
- 1292US7135573B2Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamineENANTA PHARM INC·Filed 2005·Granted Nov 14, 2006·18 cites·5 claims
- 1391US8268776B2Macrocylic oximyl hepatitis C protease inhibitorsSUN YING·Filed 2008·Granted Sep 18, 2012·15 cites·27 claims
- 1490US8372802B2Fluorinated macrocyclic compounds as hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2009·Granted Feb 12, 2013·12 cites·24 claims
- 1589US8124584B2Macrocyclic hepatitis C serine protease inhibitorsMIAO ZHENWEI·Filed 2009·Granted Feb 28, 2012·6 cites·46 claims
- 1689US7728148B2Acyclic oximyl hepatitis C protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Jun 1, 2010·7 cites·3 claims
- 1789US7384921B2Polymorphic forms of 6-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Jun 10, 2008·11 cites·10 claims
- 1888US9464255B2Maleinized ester derivativesELEVANCE RENEWABLE SCIENCES·Filed 2016·Granted Oct 11, 2016·2 cites·20 claims
- 1987USRE42375EQuinoxalinyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2008·Granted May 17, 2011·7 cites·14 claims
- 2087US7414030B26-11 Bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2005·Granted Aug 19, 2008·12 cites·25 claims
- 2187US7265094B29N-substituted 6-11 bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2005·Granted Sep 4, 2007·11 cites·20 claims
- 2286US7022679B2Processes for the preparation of 6-11 bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2004·Granted Apr 4, 2006·21 cites·56 claims
- 2386US5132322AEtoposide analoguesUNIV NORTH CAROLINA·Filed 1989·Granted Jul 21, 1992·22 cites·9 claims
- 2485US7291602B211,12-lactone bicyclolidesENANTA PHARM INC·Filed 2005·Granted Nov 6, 2007·9 cites·23 claims
- 2584US9481850B2Maleinized ester derivativesELEVANCE RENEWABLE SCIENCES·Filed 2016·Granted Nov 1, 2016·2 cites·17 claims
- 2683US8211891B2Difluoromethyl-containing macrocyclic compounds as hepatitis C virus inhibitorsGAI YONGHUA·Filed 2009·Granted Jul 3, 2012·4 cites·188 claims
- 2783US7910587B2Quinoxalinyl dipeptide hepatitis C virus inhibitorsENANTA PHARM INC·Filed 2008·Granted Mar 22, 2011·2 cites·93 claims
- 2883US7718769B2Tri-peptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2006·Granted May 18, 2010·4 cites·10 claims
- 2983US7538225B2Processes for the preparation of o-(6-pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamineENANTA PHARM INC·Filed 2005·Granted May 26, 2009·3 cites·9 claims
- 3082US8030307B2Bicyclic, C5-substituted proline derivatives as inhibitors of the hepatitis C virus NS3 proteaseENANTA PHARM INC·Filed 2008·Granted Oct 4, 2011·6 cites·17 claims
- 3182US7229972B23,6-BicyclolidesENANTA PHARM INC·Filed 2004·Granted Jun 12, 2007·15 cites·37 claims
- 3280US7906513B2Hydrazide-containing hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Mar 15, 2011·5 cites·10 claims
- 3379US8263549B2C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitorsMOORE JOEL D·Filed 2008·Granted Sep 11, 2012·6 cites·18 claims
- 3479US7718612B2Pyridazinonyl macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted May 18, 2010·1 cites·4 claims
- 3577US7419962B23,6-bicyclolidesENANTA PHARM INC·Filed 2005·Granted Sep 2, 2008·3 cites·47 claims
- 3676US7563877B2Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxylamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182ENANTA PHARM INC·Filed 2007·Granted Jul 21, 2009·2 cites·10 claims
- 3775US8501681B2Macrocyclic hepatitis C virus serine protease inhibitorsNIU DEQIANG·Filed 2007·Granted Aug 6, 2013·2 cites·15 claims
- 3875US8377872B2Cyclic P3 tripeptide hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2007·Granted Feb 19, 2013·2 cites·80 claims
- 3975US7517859B2Spirocyclic bicyclolidesENANTA PHARM INC·Filed 2006·Granted Apr 14, 2009·2 cites·11 claims
- 4075US7312201B2Tetracyclic bicyclolidesENANTA PHARM INC·Filed 2005·Granted Dec 25, 2007·2 cites·23 claims
- 4174US9944860B2Methods for treating a metathesis feedstock with metal alkoxidesELEVANCE RENEWABLE SCIENCES·Filed 2014·Granted Apr 17, 2018·3 cites·11 claims
- 4273US8324155B2Quinoxaline-containing compounds as hepatitis C virus inhibitorsGAI YONGHUA·Filed 2008·Granted Dec 4, 2012·1 cites·29 claims
- 4368US7842813B2Processes for the preparation of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamineENANTA PHARM INC·Filed 2009·Granted Nov 30, 2010·1 cites·12 claims
- 4466US7407942B23,6-bridged 9,12-oxolidesEMATA PHARMACEUTICALS INC·Filed 2006·Granted Aug 5, 2008·1 cites·24 claims
- 4564US7919627B2Processes for the preparation of hydroxylaminesENANTA PHARM INC·Filed 2008·Granted Apr 5, 2011·0 cites·10 claims
- 4664US2015057204A1Maleanized Ester DerivativesELEVANCE RENEWABLE SCIENCES·Filed 2014·Application pending·0 cites
- 4762US8273709B2Triazole-containing macrocyclic HCV serine protease inhibitorsGAI YONGHUA·Filed 2008·Granted Sep 25, 2012·0 cites·144 claims
- 4862US8236807B2Quinoxalinyl macrocyclic hepatitis C serine protease inhibitorsNAKAJIMA SUANNE·Filed 2009·Granted Aug 7, 2012·0 cites·7 claims
- 4961US9242974B2Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivativesENANTA PHARM INC·Filed 2013·Granted Jan 26, 2016·0 cites·11 claims
- 5061US8552162B2Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivativesXU GUOYOU·Filed 2009·Granted Oct 8, 2013·0 cites·23 claims
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhe Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →